transignal combo protein/dna arrays (Panomics Inc)
Structured Review
Transignal Combo Protein/Dna Arrays, supplied by Panomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combo+protein+dna+array/transignal+protein+dna+array+i/pmc07709554-159-0-4
Average 90 stars, based on 1 article reviews
Images
Related Articles
Binding Assay:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, Transformation Assay:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, Activation Assay:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, Isolation:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, Activity Assay:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, DNA Array:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, Protein Array:Article Title: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression Article Snippet: Furthermore, the Article Title: Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer. Article Snippet: 24 h after various treatments, Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium Article Snippet: Article Title: Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium. Article Snippet: Article Title: Dusquetide modulates innate immune response through binding to p62. Article Snippet: Article Article Title: Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia Article Snippet: Article Title: Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer Article Snippet: 24 h after various treatments, |

